Compare PTCT & OMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTCT | OMAB |
|---|---|---|
| Founded | 1998 | 1998 |
| Country | United States | Mexico |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Aerospace |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.8B |
| IPO Year | 2006 | N/A |
| Metric | PTCT | OMAB |
|---|---|---|
| Price | $62.76 | $110.81 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 17 | 3 |
| Target Price | $79.41 | ★ $106.00 |
| AVG Volume (30 Days) | ★ 1.0M | 71.4K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.80% |
| EPS Growth | ★ 264.48 | N/A |
| EPS | ★ 7.78 | N/A |
| Revenue | ★ $264,734,000.00 | N/A |
| Revenue This Year | N/A | $10.31 |
| Revenue Next Year | $21.65 | $12.39 |
| P/E Ratio | ★ $8.14 | $21.86 |
| Revenue Growth | ★ 36.19 | N/A |
| 52 Week Low | $35.95 | $70.24 |
| 52 Week High | $87.50 | $134.99 |
| Indicator | PTCT | OMAB |
|---|---|---|
| Relative Strength Index (RSI) | 21.26 | 35.22 |
| Support Level | $57.74 | $99.42 |
| Resistance Level | $63.19 | $111.48 |
| Average True Range (ATR) | 2.77 | 4.86 |
| MACD | -0.57 | -2.55 |
| Stochastic Oscillator | 8.82 | 7.84 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Grupo Aeroportuario del Centro Norte SAB de CV operates airports in the central region of Mexico. The airport is in Monterrey, which serves nearly half of the company's total passengers. In addition, the company manages two hotels and one industrial park. Its reportable segments include its airports, the Terminal 2 NH Collection Hotel, the Hilton Garden Inn Hotel and the OMA-VYNMSA Industrial Park, individually, and information about its holding company and other companies is combined in the Others.